Blis Technologies Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Blis Technologies Ltd with three other pharmaceutical manufacturers in Australasia: Acrux Ltd of Australia (2019 sales of 5.29 million Australian Dollars [US$3.64 million] of which 12% was Other), Avita Medical Limited of Australia (8.16 million Australian Dollars [US$5.62 million] of which 76% was Operating-Americas.), and Micro-X Ltd which is also based in Australia (5.31 million Australian Dollars [US$3.66 million] of which 100% was Manufacturing of ultra lightweight carbo).

Sales Analysis. During the year ended March of 2019, sales at Blis Technologies Ltd were 8.41 million New Zealand Dollars (US$5.35 million). This is an increase of 59.0% versus 2018, when the company's sales were 5.29 million New Zealand Dollars.